Phase
Condition
Dysrhythmia
Low Blood Pressure (Hypotension)
Congestive Heart Failure
Treatment
Amvia/Solvia pacemaker family
Clinical Study ID
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Standard indication for de novo, upgrade or replacement pacemaker or cardiacresynchronization therapy pacemaker (CRT-P) implantation
Ability to understand the nature of the study
Willingness to provide written informed consent
Ability and willingness to perform all follow-up visits at the study site
Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIKHome Monitoring® concept
Exclusion
Exclusion Criteria:
Planned for conduction system pacing
Planned cardiac surgical procedures or interventional measures other than the studyprocedure within the next 12 months
Known pregnancy or breast feeding
Age less than 18 years
Participation in another interventional clinical investigation
Life-expectancy less than 12 months
Study Design
Connect with a study center
Kepler Universitätsklinikum
Linz,
AustriaSite Not Available
Elisabeth-Krankenhaus Essen
Essen,
GermanySite Not Available
Kliniken Maria Hilf GmbH
Mönchengladbach,
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.